At present, there are three FDA-approved drugs (donepezil, galantamine and rivastigmine) [10] that ameliorate AD symptoms by inhibiting acetylcholinesterase (AChE), the enzyme responsible for the hydrolysis of ACh, and by rising the ACh content in the synapsis [11]. The gene discussed is ACHE; the disease is Alzheimer disease.